Noel Christopher W, Isenberg Jordan, Goldich Yakov, Conlon Ronan, Teichman Joshua, Rubinger Daniel A, Weinberg Tessa A I, Slomovic Jaclyn, Chan Clara C, Rootman David S, Baig Kashif M, Slomovic Allan R
Department of Ophthalmology, Toronto Western Hospital, University of Toronto, Toronto, Ont.
Department of Ophthalmology, Toronto Western Hospital, University of Toronto, Toronto, Ont.
Can J Ophthalmol. 2016 Apr;51(2):76-82. doi: 10.1016/j.jcjo.2015.12.015.
To report the outcomes of patients who underwent Boston type 1 keratoprosthesis (Kpro) surgery at the University Health Network (Toronto, Ont.) and the University of Ottawa Eye Institute (Ottawa, Ont.) between June 2008 and July 2013.
Retrospective case series.
Forty-four eyes of 43 patients who underwent Kpro surgery.
A retrospective review was conducted of all Kpro procedures performed by 4 attending cornea surgeons. The preoperative characteristics and postoperative course of each patient were analyzed.
In 31 eyes (70%), the primary indication for a Kpro was failed corneal transplantation. The remaining 13 eyes (30%) had Kpro as a primary procedure. In all eyes, preoperative visual acuity (VA) was 20/150 or worse, with 39 eyes (89%) having a VA of counting fingers, hand movement, or light perception. Mean follow-up time was 21 ± 12 months (range 12-57 months). The retention rate at the last follow-up was 95%. Best-achieved median VA was 20/100 (range 20/20 to no light perception [NLP]), with 37% of patients achieving a VA of >20/40 at some point during their postoperative course. At the last follow-up, median VA was 20/400 (range 20/30 to NLP). The 2 most common complications included retroprosthetic membrane formation (23 eyes, 52%) and elevated intraocular pressure (10 eyes, 23%). There were 5 cases (11%) of stromal melt and 1 case (2%) of infective keratitis.
This study demonstrates that Kpro improves VA in a majority of cases, and is a viable option in situations in which there is a poor prognosis for traditional penetrating keratoplasty.
报告2008年6月至2013年7月期间在大学健康网络(多伦多,安大略省)和渥太华大学眼科研究所(渥太华,安大略省)接受波士顿1型角膜移植术(Kpro)的患者的治疗结果。
回顾性病例系列研究。
43例接受Kpro手术患者的44只眼。
对4位角膜外科主治医生所进行的所有Kpro手术进行回顾性研究。分析每位患者的术前特征和术后病程。
31只眼(70%)进行Kpro手术的主要指征是角膜移植失败。其余13只眼(30%)将Kpro作为初次手术。所有眼中,术前视力(VA)为20/150或更差,39只眼(89%)的视力为指数、手动或光感。平均随访时间为21±12个月(范围12 - 57个月)。最后一次随访时的保留率为95%。最佳达到的中位视力为20/100(范围20/20至无光感[NLP]),37%的患者在术后病程中的某个时间点视力达到>20/40。在最后一次随访时,中位视力为20/400(范围20/30至无光感)。2种最常见的并发症包括人工角膜后膜形成(23只眼,52%)和眼压升高(10只眼,23%)。有5例(11%)基质溶解和1例(2%)感染性角膜炎。
本研究表明,Kpro在大多数情况下可改善视力,并且在传统穿透性角膜移植预后不良的情况下是一种可行的选择。